Ton Berkien - Nuevolution
And finally this week, Ton Berkien is set to join small molecule lead discovery company Nuevolution as Chief Business Officer, beginning next year.
Berkien most recently served as Senior Director Corporate Development at Takeda Pharmaceuticals, where he was responsible for a number of M&A transactions.
“During 2014, Nuevolution will be in a position to out-license its first internal programs and further programs will rapidly follow,” said CEO Alex Gouliaev. “We are very pleased that Ton has accepted to join us and look forward to benefit from his expertise in the commercialization of Nuevolutions internal programs.”